Autoantibodies to oxidized low density lipoprotein in relation with coronary artery disease
- PMID: 19729805
- DOI: 10.3233/HAB-2009-0202
Autoantibodies to oxidized low density lipoprotein in relation with coronary artery disease
Abstract
The relationship between autoantibodies (autoAbs) to oxidized LDL (oxLDL) and coronary artery disease (CAD) remains controversial. IgM and IgG autoAbs to oxLDL and 1-palmitoyl-2 (5'-oxo-valeroyl)-sn-glycero-3-phosphorylcholine (POVPC), as well as the levels of non modified or modified ApoB-100 immune complexes (ICs), were measured in twenty patients undergoing clinically indicated coronary angiography, and in ten young healthy volunteer sera. The levels of IgM autoAbs to oxLDL did not differ between no CAD patients and healthy subjects, but the levels of these autoAbs were significantly higher in no CAD patients and healthy subjects in comparison with CAD patients. There was not difference in the levels of IgM anti-ApoB-100 ICs between both groups of patients. In contrast, the levels of ICs formed by IgM autoAbs and oxidative modified ApoB-100 were lower in patients with CAD than in patients without CAD. No differences were observed in the levels of autoAbs to POVPC among the groups. In conclusion, our results showed that the level of circulating oxLDL IgM autoAbs was lower in CAD patients than in no CAD patients, supporting the hypothesis that this kind of autoAbs might be inversely associated with the presence of atherosclerosis.
Similar articles
-
Soluble LDL-immune complexes in type 2 diabetes and vascular disease.Horm Metab Res. 2002 Apr;34(4):196-201. doi: 10.1055/s-2002-26706. Horm Metab Res. 2002. PMID: 11987029
-
Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.J Pharm Pharmacol. 2002 Dec;54(12):1651-7. doi: 10.1211/002235702306. J Pharm Pharmacol. 2002. PMID: 12542895
-
Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events.J Lipid Res. 2007 Feb;48(2):425-33. doi: 10.1194/jlr.M600361-JLR200. Epub 2006 Nov 8. J Lipid Res. 2007. PMID: 17093289
-
Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.Minerva Cardioangiol. 2007 Dec;55(6):821-37. Minerva Cardioangiol. 2007. PMID: 18091649 Review.
-
The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.Ann N Y Acad Sci. 2005 Jun;1051:442-54. doi: 10.1196/annals.1361.086. Ann N Y Acad Sci. 2005. PMID: 16126986 Review.
Cited by
-
Cardiovascular risk factors: The effects of ageing and smoking on the immune system, an observational clinical study.Front Immunol. 2022 Sep 15;13:968815. doi: 10.3389/fimmu.2022.968815. eCollection 2022. Front Immunol. 2022. PMID: 36189218 Free PMC article.
-
Depletion of Homeostatic Antibodies against Malondialdehyde-Modified Low-Density Lipoprotein Correlates with Adverse Events in Major Vascular Surgery.Antioxidants (Basel). 2022 Jan 29;11(2):271. doi: 10.3390/antiox11020271. Antioxidants (Basel). 2022. PMID: 35204154 Free PMC article.
-
The Effect of a 13-Valent Conjugate Pneumococcal Vaccine on Circulating Antibodies Against Oxidized LDL and Phosphorylcholine in Man, A Randomized Placebo-Controlled Clinical Trial.Biology (Basel). 2020 Oct 22;9(11):345. doi: 10.3390/biology9110345. Biology (Basel). 2020. PMID: 33105582 Free PMC article.
-
Cardiotrophin-1 Deficiency Abrogates Atherosclerosis Progression.Sci Rep. 2020 Apr 1;10(1):5791. doi: 10.1038/s41598-020-62596-6. Sci Rep. 2020. PMID: 32238841 Free PMC article.
-
Anti-Oxidized LDL Antibodies and Coronary Artery Disease: A Systematic Review.Antioxidants (Basel). 2019 Oct 15;8(10):484. doi: 10.3390/antiox8100484. Antioxidants (Basel). 2019. PMID: 31618991 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
